SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Patient Monitoring

PUBLISHER: Grand View Research | PRODUCT CODE: 2151529

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2151529

Ambulatory Blood Pressure Monitoring Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

The global ambulatory blood pressure monitoring devices market size was valued at USD 1.6 billion in 2025 and is projected to grow from USD 1.7 billion in 2026 to USD 3.8 billion by 2033, at a CAGR of 11.6% from 2026 to 2033. North America dominated the global market, accounting for the largest revenue share of 40.0% in 2025. The market is primarily driven by the growing geriatric population, increasing prevalence of chronic diseases such as hypertension, and ongoing technological advancements in blood pressure monitoring solutions. According to the World Health Organization (WHO) Hypertension Fact Sheet updated in 2025, an estimated 1.4 billion adults aged 30-79 years worldwide were living with hypertension in 2024. Hypertension remains one of the leading causes of premature mortality globally and contributes significantly to the burden of cardiovascular diseases, including heart attack, stroke, and kidney disorders.

Furthermore, WHO reports that nearly two-thirds of individuals with hypertension reside in low- and middle-income countries, where diagnosis and disease management remain major healthcare challenges. These factors are increasing the need for reliable blood pressure screening and continuous monitoring solutions, thereby driving demand for ambulatory blood pressure monitoring devices worldwide.

The growing geriatric population is a key factor driving demand for ambulatory blood pressure monitoring (ABPM) devices. According to the United Nations International Day of Older Persons update published in 2025, the global population aged 60 years and above reached approximately 1.2 billion in 2025 and is projected to increase to 2.1 billion by 2050. As older adults are more susceptible to hypertension, cardiovascular diseases, and other age-related health conditions, the expanding elderly population is expected to drive sustained demand for continuous, accurate, and non-invasive blood pressure monitoring technologies.

Furthermore, ongoing technological advancements in ABPM devices are expected to support market growth throughout the forecast period. The increasing adoption of digital, connected, and mobile-enabled blood pressure monitoring technologies is enhancing patient convenience, data accessibility, and remote care capabilities. For instance, in April 2026, OMRON Healthcare announced its support for May Measurement Month 2026 through the donation of 3,000 advanced blood pressure monitors capable of detecting probable atrial fibrillation, highlighting the industry's growing focus on early disease detection and remote cardiovascular monitoring. Such developments are expected to accelerate the adoption of advanced blood pressure monitoring solutions and strengthen the broader market for ambulatory monitoring technologies worldwide.

Global Ambulatory Blood Pressure Monitoring Devices Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global ambulatory blood pressure monitoring devices market report based on product, end use, and region:

  • Product Outlook (Revenue, USD B illion, 2021 - 2033)

Ambulatory Blood Pressure Monitors

Instrument & Accessories

    • Blood Pressure Cuffs
    • Others Type
  • End Use Outlook (Revenue, USD B illion, 2021 - 2033)

Hospitals

Ambulatory Surgical Centers & Clinics

Homecare

  • Regional Outlook (Revenue, USD B illion , 2021 - 2033)

North America

    • U.S.
    • Canada
    • Mexico

Europe

    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Asia Pacific

    • Japan
    • China
    • India
    • South Korea
    • Australia
    • Thailand

Latin America

    • Brazil
    • Argentina

Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68040-206-0

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. End-use
    • 1.2.3. Regional scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in Asia Pacific
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. End-use outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ambulatory Blood Pressure Monitoring Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
    • 3.2.3. Market opportunity analysis
      • 3.2.3.1. Increasing prevalence of chronic diseases
  • 3.3. Ambulatory Blood Pressure Monitoring Devices Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Ambulatory Blood Pressure Monitoring Devices Market: Prevalence Data, By Region
    • 3.4.1. North America
      • 3.4.1.1. U.S.
      • 3.4.1.2. Canada
      • 3.4.1.3. Mexico
    • 3.4.2. Europe
      • 3.4.2.1. UK
      • 3.4.2.2. Germany
      • 3.4.2.3. France
      • 3.4.2.4. Italy
      • 3.4.2.5. Spain
      • 3.4.2.6. Denmark
      • 3.4.2.7. Sweden
      • 3.4.2.8. Norway
    • 3.4.3. Asia Pacific
      • 3.4.3.1. Japan
      • 3.4.3.2. China
      • 3.4.3.3. India
      • 3.4.3.4. South Korea
      • 3.4.3.5. Australia
      • 3.4.3.6. Thailand
    • 3.4.4. Latin America
      • 3.4.4.1. Brazil
      • 3.4.4.2. Argentina
    • 3.4.5. Middle East and Africa (MEA)
      • 3.4.5.1. South Africa
      • 3.4.5.2. Saudi Arabia
      • 3.4.5.3. UAE
      • 3.4.5.4. Kuwait

Chapter 4. Ambulatory Blood Pressure Monitoring Devices Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global ambulatory blood pressure monitoring devices Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Ambulatory blood pressure monitors
    • 4.5.1. Market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Instrument & accessories
    • 4.6.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.2. Blood Pressure Cuffs
      • 4.6.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 4.6.3. Others
      • 4.6.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Ambulatory Blood Pressure Monitoring Devices Market: End-use Estimates & Trend Analysis

  • 5.1. End-use Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global ambulatory blood pressure monitoring devices Market by End-use Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecasts 2021 to 2033 (USD million)
    • 5.4.2. Ambulatory Surgical Centers & Clinics
      • 5.4.2.1. Market estimates and forecasts 2021 to 2033 (USD Million)
    • 5.4.3. Homecare
      • 5.4.3.1. Market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Ambulatory Blood Pressure Monitoring Devices Market: Regional Estimates & Trend Analysis by Product & End-use

  • 6.1. Regional Market Share Analysis, 2023 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Global Regional Market Snapshot
  • 6.4. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 6.5. North America
    • 6.5.1. U.S.
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.5.2. Canada
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.5.3. Mexico
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.6. Europe
    • 6.6.1. UK
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.2. Germany
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.3. France
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. France market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.4. Italy
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.5. Spain
      • 6.6.5.1. Key country dynamics
      • 6.6.5.2. Regulatory framework/ reimbursement structure
      • 6.6.5.3. Competitive scenario
      • 6.6.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.6. Norway
      • 6.6.6.1. Key country dynamics
      • 6.6.6.2. Regulatory framework/ reimbursement structure
      • 6.6.6.3. Competitive scenario
      • 6.6.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.7. Sweden
      • 6.6.7.1. Key country dynamics
      • 6.6.7.2. Regulatory framework/ reimbursement structure
      • 6.6.7.3. Competitive scenario
      • 6.6.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.6.8. Denmark
      • 6.6.8.1. Key country dynamics
      • 6.6.8.2. Regulatory framework/ reimbursement structure
      • 6.6.8.3. Competitive scenario
      • 6.6.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.7. Asia Pacific
    • 6.7.1. Japan
      • 6.7.1.1. Key country dynamics
      • 6.7.1.2. Regulatory framework/ reimbursement structure
      • 6.7.1.3. Competitive scenario
      • 6.7.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.2. China
      • 6.7.2.1. Key country dynamics
      • 6.7.2.2. Regulatory framework/ reimbursement structure
      • 6.7.2.3. Competitive scenario
      • 6.7.2.4. China market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.3. India
      • 6.7.3.1. Key country dynamics
      • 6.7.3.2. Regulatory framework/ reimbursement structure
      • 6.7.3.3. Competitive scenario
      • 6.7.3.4. India market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.4. Australia
      • 6.7.4.1. Key country dynamics
      • 6.7.4.2. Regulatory framework/ reimbursement structure
      • 6.7.4.3. Competitive scenario
      • 6.7.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.5. South Korea
      • 6.7.5.1. Key country dynamics
      • 6.7.5.2. Regulatory framework/ reimbursement structure
      • 6.7.5.3. Competitive scenario
      • 6.7.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.7.6. Thailand
      • 6.7.6.1. Key country dynamics
      • 6.7.6.2. Regulatory framework/ reimbursement structure
      • 6.7.6.3. Competitive scenario
      • 6.7.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.8. Latin America
    • 6.8.1. Brazil
      • 6.8.1.1. Key country dynamics
      • 6.8.1.2. Regulatory framework/ reimbursement structure
      • 6.8.1.3. Competitive scenario
      • 6.8.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.8.2. Argentina
      • 6.8.2.1. Key country dynamics
      • 6.8.2.2. Regulatory framework/ reimbursement structure
      • 6.8.2.3. Competitive scenario
      • 6.8.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
  • 6.9. MEA
    • 6.9.1. South Africa
      • 6.9.1.1. Key country dynamics
      • 6.9.1.2. Regulatory framework/ reimbursement structure
      • 6.9.1.3. Competitive scenario
      • 6.9.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.9.2. Saudi Arabia
      • 6.9.2.1. Key country dynamics
      • 6.9.2.2. Regulatory framework/ reimbursement structure
      • 6.9.2.3. Competitive scenario
      • 6.9.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.9.3. UAE
      • 6.9.3.1. Key country dynamics
      • 6.9.3.2. Regulatory framework/ reimbursement structure
      • 6.9.3.3. Competitive scenario
      • 6.9.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)
    • 6.9.4. Kuwait
      • 6.9.4.1. Key country dynamics
      • 6.9.4.2. Regulatory framework/ reimbursement structure
      • 6.9.4.3. Competitive scenario
      • 6.9.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million) (Number of Patients Treated in Thousands)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. List of key distributors and channel partners
    • 7.3.2. Key customers
    • 7.3.3. Key company market share analysis, 2023
    • 7.3.4. Omron Healthcare Welch Allyn, Inc.
      • 7.3.4.1. Company overview
      • 7.3.4.2. Financial performance
      • 7.3.4.3. Product benchmarking
      • 7.3.4.4. Strategic initiatives
    • 7.3.5. A&D Medical Inc.
      • 7.3.5.1. Company overview
      • 7.3.5.2. Financial performance
      • 7.3.5.3. Product benchmarking
      • 7.3.5.4. Strategic initiatives
    • 7.3.6. Microlife Corporation
      • 7.3.6.1. Company overview
      • 7.3.6.2. Financial performance
      • 7.3.6.3. Product benchmarking
      • 7.3.6.4. Strategic initiatives
    • 7.3.7. Daray Medical
      • 7.3.7.1. Company overview
      • 7.3.7.2. Financial performance
      • 7.3.7.3. Product benchmarking
      • 7.3.7.4. Strategic initiatives
    • 7.3.8. Withings
      • 7.3.8.1. Company overview
      • 7.3.8.2. Financial performance
      • 7.3.8.3. Product benchmarking
      • 7.3.8.4. Strategic initiatives
    • 7.3.9. Briggs Healthcare
      • 7.3.9.1. Company overview
      • 7.3.9.2. Financial performance
      • 7.3.9.3. Product benchmarking
      • 7.3.9.4. Strategic initiatives
    • 7.3.10. GE Healthcare
      • 7.3.10.1. Company overview
      • 7.3.10.2. Financial performance
      • 7.3.10.3. Product benchmarking
      • 7.3.10.4. Strategic initiatives
    • 7.3.11. Rossmax International Ltd.
      • 7.3.11.1. Company overview
      • 7.3.11.2. Financial performance
      • 7.3.11.3. Product benchmarking
      • 7.3.11.4. Strategic initiatives
    • 7.3.12. GF Health Products Inc
      • 7.3.12.1. Company overview
      • 7.3.12.2. Financial performance
      • 7.3.12.3. Product benchmarking
      • 7.3.12.4. Strategic initiatives
    • 7.3.13. Spacelabs Healthcare Inc.
      • 7.3.13.1. Company overview
      • 7.3.13.2. Financial performance
      • 7.3.13.3. Product benchmarking
      • 7.3.13.4. Strategic initiatives
    • 7.3.14. Philips Healthcare
      • 7.3.14.1. Company overview
      • 7.3.14.2. Financial performance
      • 7.3.14.3. Product benchmarking
      • 7.3.14.4. Strategic initiatives
    • 7.3.15. Biobeat
      • 7.3.15.1. Company overview
      • 7.3.15.2. Financial performance
      • 7.3.15.3. Product benchmarking
      • 7.3.15.4. Strategic initiatives
    • 7.3.16. Spacelabs Healthcare Inc
      • 7.3.16.1. Company overview
      • 7.3.16.2. Financial performance
      • 7.3.16.3. Product benchmarking
      • 7.3.16.4. Strategic initiatives
    • 7.3.17. Bosch & Sohn GmbH & Co. KG
      • 7.3.17.1. Company overview
      • 7.3.17.2. Financial performance
      • 7.3.17.3. Product benchmarking
      • 7.3.17.4. Strategic initiatives
    • 7.3.18. GE Company,
      • 7.3.18.1. Company overview
      • 7.3.18.2. Financial performance
      • 7.3.18.3. Product benchmarking
      • 7.3.18.4. Strategic initiatives
    • 7.3.19. Schiller AG
      • 7.3.19.1. Company overview
      • 7.3.19.2. Financial performance
      • 7.3.19.3. Product benchmarking
      • 7.3.19.4. Strategic initiatives
    • 7.3.20. DAIFUKU CO. LTD
      • 7.3.20.1. Company overview
      • 7.3.20.2. Financial performance
      • 7.3.20.3. Product benchmarking
      • 7.3.20.4. Strategic initiative
Show more
Product Code: GVR-4-68040-206-0

List of Tables

  • Table 1. List of abbreviation
  • Table 2. North America ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 3. North America ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 4. North America ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 5. U.S. ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 6. U.S. ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 7. Canada ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 8. Canada ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 9. Mexico ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 10. Mexico ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 11. Europe ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 12. Europe ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 13. Europe ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 14. Germany ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 15. Germany ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 16. UK ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 17. UK ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 18. France ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 19. France ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 20. Italy ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 21. Italy ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 22. Spain ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 23. Spain ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 24. Denmark ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 25. Denmark ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 26. Sweden ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 27. Sweden ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 28. Norway ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 29. Norway ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 30. Asia Pacific ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 31. Asia Pacific ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 32. Asia Pacific ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 33. China ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 34. China ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 35. Japan ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 36. Japan ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 37. India ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 38. India ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 39. South Korea ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 40. South Korea ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 41. Australia ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 42. Australia ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 43. Thailand ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 44. Thailand ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 45. Latin America ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 46. Latin America ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 47. Latin America ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 48. Brazil ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 49. Brazil ambulatory blood pressure monitoring devices market, by end-use (USD Million) 2018-20
  • Table 50. Argentina ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 51. Argentina ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 52. MEA ambulatory blood pressure monitoring devices market, by country (USD Million) (Number of Patients Treated in Thousands) 2018-2030
  • Table 53. MEA ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 54. MEA ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 55. South Africa ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 56. South Africa ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 57. Saudi Arabia ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 58. Saudi Arabia ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 59. UAE ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 60. UAE ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)
  • Table 61. Kuwait ambulatory blood pressure monitoring devices market, by product, 2021 - 2033 (USD Million)
  • Table 62. Kuwait ambulatory blood pressure monitoring devices market, by end-use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Ambulatory blood pressure monitoring devices market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain-based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 Market dynamics
  • Fig. 11 Prevalence of rheumatoid arthritis in 2022, by WHO regions
  • Fig. 12 Porter's five forces analysis
  • Fig. 13 PESTLE analysis
  • Fig. 14 Ambulatory blood pressure monitoring devices market: Products outlook and key takeaways
  • Fig. 15 Ambulatory blood pressure monitoring devices market: Product movement analysis
  • Fig. 16 Ambulatory blood pressure monitors market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 17 Instrument & accessories market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 18 Blood pressure cuffs market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 19 Others market estimates and forecast, 2021-2033, USD Million
  • Fig. 20 Ambulatory blood pressure monitoring devices market: End-use outlook and key takeaways
  • Fig. 21 Ambulatory blood pressure monitoring devices market: End-use movement analysis
  • Fig. 22 Hospitals market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 23 Ambulatory Surgical Centers & Clinics market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 24 Home-care market estimates and forecast, 2021-2033 (USD Million)
  • Fig. 25 Provincial marketplace: Key takeaways (1/2)
  • Fig. 26 Provincial marketplace: Key takeaways (2/2)
  • Fig. 27 North America ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 28 Key country dynamics
  • Fig. 29 U.S. ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 30 Key country dynamics
  • Fig. 31 Canada ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 32 Europe ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 33 Key country dynamics
  • Fig. 34 UK ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 35 Key country dynamics
  • Fig. 36 Germany ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 37 Key country dynamics
  • Fig. 38 France ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 39 Key country dynamics
  • Fig. 40 Spain ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 41 Key country dynamics
  • Fig. 42 Italy ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 43 Key country dynamics
  • Fig. 44 Denmark ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 45 Key country dynamics
  • Fig. 46 Sweden ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 47 Key country dynamics
  • Fig. 48 Norway ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 49 Rest of Europe Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021-2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 50 Asia Pacific ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 51 Key country dynamics
  • Fig. 52 Reimbursement scenario
  • Fig. 53 Japan ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 54 Key country dynamics
  • Fig. 55 Regulatory framework
  • Fig. 56 Reimbursement scenario
  • Fig. 57 China ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 58 Key country dynamics
  • Fig. 59 Reimbursement scenario
  • Fig. 60 India ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 61 Key country dynamics
  • Fig. 62 Australia ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 63 Key country dynamics
  • Fig. 64 South Korea Ambulatory blood pressure monitoring devices market estimates and forecasts, 2018 -2030 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 65 Key country dynamics
  • Fig. 66 Thailand ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 67 Key country dynamics
  • Fig. 68 Malaysia ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 69 Key country dynamics
  • Fig. 70 Vietnam ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 71 Key country dynamics
  • Fig. 72 Philippines ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 73 Rest of Asia Pacific Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021-2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 74 Latin America ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 75 Key country dynamics
  • Fig. 76 Brazil regulation details
  • Fig. 77 Reimbursement scenario
  • Fig. 78 Brazil ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 79 Key country dynamics
  • Fig. 80 Argentina pharmaceuticals registration details
  • Fig. 81 Argentina ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 82 Key country dynamics
  • Fig. 83 Regulatory framework
  • Fig. 84 Reimbursement scenario
  • Fig. 85 Mexico ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 86 Rest of Latin America Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021-2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 87 MEA Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million)
  • Fig. 88 Key country dynamics
  • Fig. 89 South Africa ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 90 Key country dynamics
  • Fig. 91 Saudi Arabia ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 92 Key country dynamics
  • Fig. 93 UAE Ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 94 Key country dynamics
  • Fig. 95 Kuwait ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 96 Key country dynamics
  • Fig. 97 Turkey ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 98 Rest of MEA ambulatory blood pressure monitoring devices market estimates and forecasts, 2021 - 2033 (USD million) (Number of Patients Treated in Thousands)
  • Fig. 99 Company market share analysis, 2023
  • Fig. 100 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!